LUNGevity Foundation shared a post on LinkedIn:
“‘Today’s research is tomorrow’s cure. If we want to see continued breakthroughs and advancements in lung cancer, we must secure a strong pipeline of researchers dedicated to improving outcomes for people with lung cancer,’ Upal Basu Roy, PhD, MPH, Executive Director of Research at LUNGevity Foundation.
The 2025 awardees represent early-career investigators working on projects that address some of the most pressing needs in lung cancer today. Through these awards, LUNGevity continues to drive innovation and hope—empowering scientists to make discoveries that will change what it means to be diagnosed with lung cancer.
LUNGevity is proud to announce the following recipients of our 2025 Translational Research Program Awards.
Learn more about LUNGevity research.”
More posts about LUNGevity Foundation.
